Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  spleen tyrosine kinase inhibitor TAK-659
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C34001, NCI-2013-02382, 15/LO/0302, 2013-002292-18, U1111-1165-3590, NCT02000934
Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: C34002, NCI-2015-00064, U1111-1163-2185, NCT02323113
A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: C34003, NCI-2016-01821, 2016-000853-10, U1111-1181-8312, NCT02834247
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: C34005, NCI-2016-01823, 2016-001426-34, U1111-1188-0891, NCT02954406
Start Over